An Alzheimer's drug that had been hailed as a major breakthrough may actually increase patients' chance of dying, according ...

Alzheimer’s disease patients who are prescribed fistfuls of daily medicines are at greater risk of long-term harm, including ...

New research reveals that lecanemab, an Alzheimer's drug previously hailed for slowing disease progression, may increase the ...

The Alzheimer's medication lecanemab, which was once hailed as a breakthrough, is currently under investigation because of serious side effects. Concerning side effects have hampered lecanemab's ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS in England, the drugs spending watchdog says. Donanemab was hailed as a turning ...

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

Three drugs approved for Alzheimer’s disease have been hailed as a breakthrough in treating the condition – how effective are they, and what risks and side effects do they come with?

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

AbbVie (ABBV) announced Monday that it is buying Aliada Therapeutics for $1.4 billion. The deal includes Aliada’s lead drug ...

Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of ...